$5.36
0.000.00%
Pre-Market: 4:00 PM EDT
Track the latest Myomo insider trading activity. Stay informed on recent buys, sells, and market impact for Myomo stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Myomo Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 75.94K shares worth $420.39K, meanwhile, insiders have reported buying a total of 7.40K shares for a total value of $37.00K.
Mar 14, 2025 | THOMAS KIRK | — | 7.40K | $5.00 | $37.00K | BUY | 2.98% | 255.93K | Mar 13 | View |
Mar 14, 2025 | Micah Mitchell | CHIEF COMMERCIAL OFFICER | -48.00K | $5.16 | -$247.56K | SELL | -25.45% | 140.57K | Mar 14 | View |
Mar 13, 2025 | Harry Kovelman | CHIEF MEDICAL OFFICER | -27.94K | $5.49 | -$172.83K | SELL | -22.46% | 96.48K | Mar 11 - Mar 13 | View |
Sep 09, 2024 | Harry Kovelman | CHIEF MEDICAL OFFICER | -6.70K | $3.76 | -$25.18K | SELL | -5.14% | 123.56K | Sep 05 | View |
Sep 05, 2024 | Harry Kovelman | CHIEF MEDICAL OFFICER | -2.17K | $4.00 | -$8.68K | SELL | -1.64% | 130.26K | Sep 03 - Sep 04 | View |
May 31, 2024 | THOMAS KIRK | — | 50.00K | $3.50 | $175.00K | BUY | 26.81% | 236.50K | May 29 | View |
May 17, 2024 | Harry Kovelman | CHIEF MEDICAL OFFICER | -35.43K | $3.69 | -$130.84K | SELL | -26.55% | 98.01K | May 15 | View |
Mar 18, 2024 | THOMAS KIRK | — | 50.00K | $3.50 | $175.00K | BUY | 36.63% | 186.50K | Mar 14 | View |
Dec 14, 2023 | THOMAS KIRK | — | 50.00K | $3.10 | $155.00K | BUY | 57.80% | 136.50K | Nov 20 | View |
Dec 08, 2023 | Aloysius Thomas Crowley Jr | — | -15.00K | $0.00 | $0.00 | SELL | -33.33% | 29.99K | Dec 08 | View |
Dec 05, 2023 | Harry Kovelman | CHIEF MEDICAL OFFICER | -8.43K | $4.02 | -$397.98 | SELL | -5.65% | 140.75K | Dec 01 - Dec 05 | View |
Nov 30, 2023 | Aloysius Thomas Crowley Jr | — | -15.00K | $0.00 | $0.00 | SELL | -25.00% | 45.00K | Nov 28 | View |
Sep 11, 2023 | Mayo Milton Morris | — | 15.00K | $1.06 | $15.87K | BUY | 23.83% | 77.93K | Sep 08 | View |
Aug 31, 2023 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 48.40K | $0.74 | $36.04K | BUY | 5.83% | 878.25K | Aug 30 | View |
Aug 30, 2023 | Harry Kovelman | CHIEF MEDICAL OFFICER | 8.33K | $0.60 | $5.00K | BUY | 5.90% | 149.56K | Aug 29 | View |
Aug 30, 2023 | David A Henry | CHIEF FINANCIAL OFFICER | 41.67K | $0.60 | $25.00K | BUY | 13.42% | 352.19K | Aug 29 | View |
Aug 30, 2023 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 79.50K | $0.76 | $60.59K | BUY | 10.60% | 829.85K | Aug 28 - Aug 29 | View |
Jun 30, 2023 | Aloysius Thomas Crowley Jr | DIRECTOR | -12.90K | $2.09 | -$26.95K | SELL | -100.00% | 0.00 | Jun 06 - Jun 14 | View |
Jan 18, 2023 | Micah Mitchell | CHIEF COMMERICAL OFFICER | 15.38K | $0.33 | $5.00K | BUY | 31.12% | 64.81K | Jan 17 | View |
Jan 18, 2023 | David A Henry | CHIEF FINANCIAL OFFICER | 76.92K | $0.33 | $25.00K | BUY | 88.82% | 163.53K | Jan 17 | View |
Jan 18, 2023 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 307.69K | $0.33 | $100.00K | BUY | 175.17% | 483.35K | Jan 17 | View |
Nov 22, 2022 | David A Henry | CHIEF FINANCIAL OFFICER | 9.00K | $0.55 | $4.96K | BUY | 11.60% | 86.60K | Nov 22 | View |
Aug 08, 2022 | Aloysius Thomas Crowley Jr | DIRECTOR | -7.14K | $1.71 | -$12.22K | SELL | -35.63% | 12.90K | Aug 05 | View |
Mar 16, 2022 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 5.00K | $4.22 | $21.09K | BUY | 5.75% | 92.02K | Mar 14 | View |
Mar 11, 2022 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 5.00K | $4.63 | $23.15K | BUY | 6.10% | 87.02K | Mar 11 | View |
Nov 16, 2021 | David A Henry | CHIEF FINANCIAL OFFICER | 1.00K | $8.86 | $8.86K | BUY | 2.89% | 35.62K | Nov 16 | View |
Nov 16, 2021 | Paul R Gudonis | CHIEF EXECUTIVE OFFICER | 1.00K | $9.86 | $9.86K | BUY | 1.23% | 82.02K | Nov 12 | View |
Jul 22, 2021 | Micah Mitchell | CHIEF COMMERICAL OFFICER | -7.13K | $0.00 | $0.00 | SELL | -31.02% | 15.85K | Jul 20 - Jul 21 | View |
Browse insider trades on all stocks.